Chemotherapy: Target Therapy and Immunotherapy:@0.423628:0.035749:0.914577:0.035749:0.914577:0.019993:0.423628:0.019993:0.015644:0.011738:0.012508:0.018049:0.012604:0.006523:0.011738:0.012508:0.005792:0.013143:0.013123:0.010314:0.005330:0.005330:0.007177:0.013143:0.005809:0.012950:0.012508:0.006523:0.005330:0.008197:0.011738:0.012508:0.005792:0.013143:0.013123:0.010314:0.005330:0.013143:0.011738:0.013181:0.005330:0.004349:0.018049:0.018049:0.011699:0.011738:0.012604:0.006523:0.011738:0.012508:0.005792:0.013143:0.013123:0.010314
TREATMENT APPROACHES:@0.983689:0.278245:0.983689:0.065272:0.955679:0.065272:0.955679:0.278245:0.000000:0.000000:0.000000:0.057096:-0.123230:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.375913
9:@0.960791:0.038184:0.971327:0.038184:0.971327:0.018587:0.960791:0.018587:0.010536
HANDBOOK OF ONCOLOGY:@0.679047:0.970015:0.915156:0.970015:0.915156:0.956010:0.679047:0.956010:0.011682:0.012657:0.012657:0.012726:0.009818:0.014864:0.014864:0.010109:0.004738:0.014864:0.008296:0.004738:0.014864:0.012657:0.013906:0.014864:0.007902:0.014864:0.014915:0.010126
3.   ADJUVANT CHEMOTHERAPY :@0.084242:0.096122:0.404460:0.096122:0.404460:0.078306:0.084242:0.078306:0.011973:0.005987:0.005987:0.006356:0.000000:0.015822:0.014966:0.010263:0.013683:0.014966:0.015822:0.015822:0.008980:0.005982:0.016677:0.014539:0.011118:0.019242:0.017960:0.008980:0.014539:0.011118:0.012401:0.015822:0.011973:0.013256:0.005987
TREATMENT:@0.114538:0.114010:0.227000:0.114010:0.227000:0.096195:0.114538:0.096195:0.008980:0.012401:0.011118:0.015822:0.008980:0.019242:0.011118:0.015822:0.008980
Adjuvant  chemotherapy  refers  to  addi-:@0.084242:0.131581:0.475152:0.131581:0.475152:0.115825:0.084242:0.115825:0.014239:0.013181:0.003906:0.011699:0.010660:0.013143:0.011738:0.006523:0.005330:0.006281:0.012450:0.011738:0.012508:0.018049:0.012604:0.006523:0.011738:0.012508:0.005792:0.013143:0.013123:0.010314:0.005330:0.006275:0.005713:0.012508:0.006042:0.012508:0.005792:0.007466:0.005330:0.006281:0.006523:0.012604:0.005330:0.006277:0.013143:0.013181:0.013181:0.003848:0.006388
tional treatment  given following the pri-:@0.084242:0.147999:0.475158:0.147999:0.475158:0.132243:0.084242:0.132243:0.006523:0.003848:0.012604:0.011738:0.013143:0.003848:0.010179:0.006523:0.005711:0.012508:0.013143:0.006523:0.018049:0.012508:0.011738:0.006523:0.005330:0.004839:0.012950:0.003848:0.010660:0.012508:0.011738:0.010179:0.006042:0.012604:0.003848:0.003848:0.012604:0.015990:0.003848:0.011738:0.012950:0.010179:0.006523:0.011738:0.012508:0.010179:0.013123:0.005792:0.003848:0.006388
mary treatment with the aim to lower the :@0.084242:0.164416:0.480509:0.164416:0.480509:0.148660:0.084242:0.148660:0.018049:0.013143:0.005792:0.010314:0.006562:0.006523:0.005709:0.012508:0.013143:0.006523:0.018049:0.012508:0.011738:0.006523:0.006542:0.015990:0.003848:0.006523:0.011738:0.006562:0.006523:0.011738:0.012508:0.006546:0.013143:0.003848:0.018049:0.006562:0.006523:0.012604:0.006546:0.003848:0.012604:0.015990:0.012508:0.005792:0.006548:0.006523:0.011738:0.012508:0.005330
risk of  cancer  recurrence.  Adjuvant anti-:@0.084242:0.180833:0.475160:0.180833:0.475160:0.165078:0.084242:0.165078:0.005792:0.003848:0.007466:0.009660:0.008467:0.012604:0.006042:0.005330:0.003127:0.012450:0.013143:0.011738:0.012450:0.012508:0.005792:0.005330:0.003123:0.005713:0.012508:0.012450:0.011699:0.005792:0.005703:0.012508:0.011738:0.012450:0.012508:0.005330:0.005330:0.003123:0.014239:0.013181:0.003906:0.011699:0.010660:0.013143:0.011738:0.006523:0.008467:0.013143:0.011738:0.006523:0.003848:0.006388
cancer therapy is not restricted to chemo-:@0.084242:0.197251:0.475179:0.197251:0.475179:0.181495:0.084242:0.181495:0.012450:0.013143:0.011738:0.012450:0.012508:0.005792:0.004695:0.006523:0.011738:0.012508:0.005792:0.013143:0.013123:0.010314:0.004695:0.003848:0.007466:0.004695:0.011738:0.012604:0.006523:0.004686:0.005713:0.012508:0.007466:0.006523:0.005792:0.003848:0.012450:0.006523:0.012508:0.013181:0.004695:0.006523:0.012604:0.004695:0.012450:0.011738:0.012508:0.018049:0.012604:0.006388
therapy and may include other modali-:@0.084242:0.213668:0.475133:0.213668:0.475133:0.197912:0.084242:0.197912:0.006523:0.011738:0.012508:0.005792:0.013143:0.013123:0.010314:0.009737:0.013143:0.011738:0.013181:0.009737:0.018049:0.013143:0.010314:0.009737:0.003848:0.011738:0.012450:0.003848:0.011699:0.013181:0.012508:0.009737:0.012604:0.006523:0.011738:0.012508:0.005792:0.009737:0.018049:0.012604:0.013181:0.013143:0.003848:0.003848:0.006388
ties, including radiation therapy, hormone :@0.084242:0.230086:0.480486:0.230086:0.480486:0.214330:0.084242:0.214330:0.006523:0.003848:0.012508:0.007466:0.005330:0.005523:0.003848:0.011738:0.012450:0.003848:0.011699:0.013181:0.003848:0.011738:0.012950:0.005523:0.005792:0.013143:0.013181:0.003848:0.013143:0.006523:0.003848:0.012604:0.011738:0.005523:0.006523:0.011738:0.012508:0.005792:0.013143:0.013123:0.010314:0.005330:0.005523:0.011738:0.012604:0.006315:0.018049:0.012604:0.011738:0.012508:0.005330
therapy, targeted therapy, or biological :@0.084242:0.246503:0.480497:0.246503:0.480497:0.230747:0.084242:0.230747:0.006523:0.011738:0.012508:0.005792:0.013143:0.013123:0.010314:0.005330:0.010045:0.006523:0.013143:0.005807:0.012950:0.012508:0.006523:0.012508:0.013181:0.010045:0.006523:0.011738:0.012508:0.005792:0.013143:0.013123:0.010314:0.005330:0.010045:0.012604:0.005792:0.010045:0.013123:0.003848:0.012604:0.003848:0.012604:0.012950:0.003848:0.012450:0.013143:0.003848:0.005330
therapy.:@0.084242:0.262920:0.162713:0.262920:0.162713:0.247164:0.084242:0.247164:0.006523:0.011738:0.012508:0.005792:0.013143:0.013123:0.010314:0.005330
1,2:@0.162706:0.257336:0.178243:0.257336:0.178243:0.248150:0.162706:0.248150:0.006215:0.003107:0.006215
Malignant tumour  recurrence, either :@0.102424:0.279376:0.480493:0.279376:0.480493:0.263621:0.102424:0.263621:0.017684:0.013143:0.003848:0.003848:0.012950:0.011738:0.013143:0.011738:0.006523:0.016818:0.006523:0.011699:0.018049:0.012604:0.011699:0.005792:0.005330:0.011476:0.005713:0.012508:0.012450:0.011699:0.005792:0.005703:0.012508:0.011738:0.012450:0.012508:0.005330:0.016818:0.012508:0.003848:0.006523:0.011738:0.012508:0.005792:0.005330
locally, regionally or  systemically, follow-:@0.084240:0.295794:0.475132:0.295794:0.475132:0.280038:0.084240:0.280038:0.003848:0.012604:0.012450:0.013143:0.003848:0.003848:0.010314:0.005330:0.010045:0.005711:0.012508:0.012950:0.003848:0.012604:0.011738:0.013143:0.003848:0.003848:0.010314:0.010045:0.012604:0.005792:0.005330:0.004701:0.007466:0.010314:0.007466:0.006523:0.012508:0.018049:0.003848:0.012450:0.013143:0.003848:0.003848:0.010314:0.005330:0.010045:0.006042:0.012604:0.003848:0.003848:0.012604:0.015990:0.006388
ing surgery or  radiation is primarily due :@0.084240:0.312211:0.480501:0.312211:0.480501:0.296455:0.084240:0.296455:0.003848:0.011738:0.012950:0.011199:0.007466:0.011699:0.005809:0.012950:0.012508:0.005792:0.010314:0.011199:0.012604:0.005792:0.005330:0.005854:0.005792:0.013143:0.013181:0.003848:0.013143:0.006523:0.003848:0.012604:0.011738:0.011199:0.003848:0.007466:0.011199:0.013123:0.005792:0.003848:0.018049:0.013143:0.005792:0.003848:0.003848:0.010314:0.011199:0.013181:0.011699:0.012508:0.005330
to  occult micro-metastases spread. The :@0.084240:0.328629:0.480509:0.328629:0.480509:0.312873:0.084240:0.312873:0.006523:0.012604:0.005330:0.006029:0.012604:0.012450:0.012450:0.011699:0.003848:0.006523:0.011372:0.018049:0.003848:0.012450:0.005715:0.012604:0.006388:0.018049:0.012508:0.006523:0.013143:0.007466:0.006523:0.013143:0.007466:0.012508:0.007466:0.011372:0.007466:0.013123:0.005719:0.012508:0.013143:0.013181:0.005330:0.011372:0.008197:0.011738:0.012508:0.005330
purpose of adjuvant therapy is, therefore, :@0.084240:0.345046:0.480460:0.345046:0.480460:0.329290:0.084240:0.329290:0.013123:0.011699:0.005792:0.013123:0.012604:0.007466:0.012508:0.006196:0.012604:0.006042:0.006196:0.013143:0.013181:0.003906:0.011699:0.010660:0.013143:0.011738:0.006523:0.006196:0.006523:0.011738:0.012508:0.005792:0.013143:0.013123:0.010314:0.006196:0.003848:0.007466:0.005330:0.006196:0.006523:0.011738:0.012508:0.005705:0.012508:0.006042:0.012604:0.005705:0.012508:0.005330:0.005330
to decrease the incidence of both local :@0.084240:0.361463:0.480483:0.361463:0.480483:0.345708:0.084240:0.345708:0.006523:0.012604:0.008120:0.013181:0.012508:0.012450:0.005711:0.012508:0.013143:0.007466:0.012508:0.008130:0.006523:0.011738:0.012508:0.008126:0.003848:0.011738:0.012450:0.003848:0.013181:0.012508:0.011738:0.012450:0.012508:0.008126:0.012604:0.006042:0.008126:0.013123:0.012604:0.006523:0.011738:0.008120:0.003848:0.012604:0.012450:0.013143:0.003848:0.005330
and systemic recurrence and to improve :@0.084240:0.377881:0.480483:0.377881:0.480483:0.362125:0.084240:0.362125:0.013143:0.011738:0.013181:0.007493:0.007466:0.010314:0.007466:0.006523:0.012508:0.018049:0.003848:0.012450:0.007505:0.005711:0.012508:0.012450:0.011699:0.005792:0.005705:0.012508:0.011738:0.012450:0.012508:0.007485:0.013143:0.011738:0.013181:0.007491:0.006523:0.012604:0.007487:0.003848:0.018049:0.013123:0.005717:0.012604:0.010660:0.012508:0.005330
the overall survival  of cancer patients. :@0.084240:0.394298:0.480493:0.394298:0.480493:0.378542:0.084240:0.378542:0.006523:0.011738:0.012508:0.012738:0.012604:0.010660:0.012508:0.005792:0.013143:0.003848:0.003848:0.012738:0.007466:0.011699:0.005792:0.010660:0.003848:0.010660:0.013143:0.003848:0.005330:0.007422:0.012604:0.006042:0.012738:0.012450:0.013143:0.011738:0.012450:0.012508:0.005792:0.012738:0.013123:0.013143:0.006523:0.003848:0.012508:0.011738:0.006523:0.007466:0.005330:0.005330
It  has been  shown  that  chemotherapy :@0.084240:0.410716:0.480497:0.410716:0.480497:0.394960:0.084240:0.394960:0.004349:0.006523:0.005330:0.006646:0.011738:0.013143:0.007466:0.011988:0.013123:0.012508:0.012508:0.011738:0.005330:0.006641:0.007466:0.011738:0.012604:0.015990:0.011738:0.005330:0.006642:0.006523:0.011738:0.013143:0.006523:0.005330:0.006642:0.012450:0.011738:0.012508:0.018049:0.012604:0.006523:0.011738:0.012508:0.005792:0.013143:0.013123:0.010314:0.005330
treatments with clinical activity in the ad-:@0.084240:0.427133:0.475123:0.427133:0.475123:0.411377:0.084240:0.411377:0.006523:0.005709:0.012508:0.013143:0.006523:0.018049:0.012508:0.011738:0.006523:0.007466:0.006754:0.015990:0.003848:0.006523:0.011738:0.006754:0.012450:0.003848:0.003848:0.011738:0.003848:0.012450:0.013143:0.003848:0.006771:0.013143:0.012450:0.006523:0.003848:0.010660:0.003848:0.006523:0.010314:0.006754:0.003848:0.011738:0.006754:0.006523:0.011738:0.012508:0.006754:0.013143:0.013181:0.006388
vanced disease  setting  may  have cura-:@0.084240:0.443550:0.475165:0.443550:0.475165:0.427794:0.084240:0.427794:0.010660:0.013143:0.011738:0.012450:0.012508:0.013181:0.009313:0.013181:0.003848:0.007466:0.012508:0.013143:0.007478:0.012508:0.005330:0.003972:0.007466:0.012508:0.006523:0.006523:0.003848:0.011738:0.012950:0.005330:0.003970:0.018049:0.013143:0.010314:0.005330:0.003974:0.011738:0.013143:0.010660:0.012508:0.009313:0.012450:0.011699:0.005792:0.013143:0.006388
tive potential following  resection  of  the :@0.084240:0.459968:0.480499:0.459968:0.480499:0.444212:0.084240:0.444212:0.006523:0.003848:0.010660:0.012508:0.011064:0.013123:0.012604:0.006523:0.012508:0.011738:0.006523:0.003848:0.013143:0.003848:0.011064:0.006042:0.012604:0.003848:0.003848:0.012604:0.015990:0.003848:0.011738:0.012950:0.005330:0.005725:0.005713:0.012508:0.007466:0.012508:0.012450:0.006523:0.003848:0.012604:0.011738:0.005330:0.005719:0.012604:0.006042:0.005330:0.005723:0.006523:0.011738:0.012508:0.005330
primary tumour. It has been demonstrated :@0.084240:0.476385:0.480491:0.476385:0.480491:0.460629:0.084240:0.460629:0.013123:0.005792:0.003848:0.018049:0.013143:0.005792:0.010314:0.004859:0.006523:0.011699:0.018049:0.012604:0.011699:0.004368:0.005330:0.004853:0.004349:0.006523:0.004855:0.011738:0.013143:0.007466:0.004859:0.013123:0.012508:0.012508:0.011738:0.004851:0.013181:0.012508:0.018049:0.012604:0.011738:0.007466:0.006523:0.005792:0.013143:0.006523:0.012508:0.013181:0.005330
that  adjuvant  chemotherapy  is effective :@0.084240:0.492803:0.480478:0.492803:0.480478:0.477047:0.084240:0.477047:0.006523:0.011738:0.013143:0.006523:0.005330:0.003177:0.013143:0.013181:0.003906:0.011699:0.010660:0.013143:0.011738:0.006523:0.005330:0.003183:0.012450:0.011738:0.012508:0.018049:0.012604:0.006523:0.011738:0.012508:0.005792:0.013143:0.013123:0.010300:0.005330:0.003183:0.003848:0.007466:0.008524:0.012508:0.006094:0.006042:0.012508:0.012450:0.006523:0.003848:0.010660:0.012508:0.005330
in extending  both  disease-free  survival :@0.084240:0.509220:0.480466:0.509220:0.480466:0.493464:0.084240:0.493464:0.003848:0.011738:0.014182:0.012508:0.009236:0.006523:0.012508:0.011738:0.013181:0.003848:0.011738:0.012950:0.005330:0.008842:0.013123:0.012604:0.006523:0.011738:0.005330:0.008840:0.013181:0.003848:0.007466:0.012508:0.013143:0.007466:0.012508:0.006388:0.006042:0.005713:0.012508:0.012508:0.005330:0.008842:0.007466:0.011699:0.005792:0.010660:0.003848:0.010660:0.013143:0.003848:0.005330
(DFS) and overall survival (OS) in patients :@0.084240:0.525637:0.480472:0.525637:0.480472:0.509881:0.084240:0.509881:0.007100:0.014316:0.009333:0.009583:0.007100:0.007485:0.013143:0.011738:0.013181:0.007485:0.012604:0.010660:0.012508:0.005792:0.013143:0.003848:0.003848:0.007485:0.007466:0.011699:0.005792:0.010660:0.003848:0.010660:0.013143:0.003848:0.007497:0.007100:0.016722:0.009583:0.007100:0.007485:0.003848:0.011738:0.007485:0.013123:0.013143:0.006523:0.003848:0.012508:0.011738:0.006523:0.007466:0.005330
with malignant  diseases such  as breast :@0.084240:0.542055:0.480480:0.542055:0.480480:0.526299:0.084240:0.526299:0.015990:0.003848:0.006523:0.011738:0.011565:0.018049:0.013143:0.003848:0.003848:0.012950:0.011738:0.013143:0.011738:0.006523:0.005330:0.006225:0.013181:0.003848:0.007466:0.012508:0.013143:0.007466:0.012508:0.007466:0.011565:0.007466:0.011699:0.012450:0.011738:0.005330:0.006225:0.013143:0.007466:0.011565:0.013123:0.005715:0.012508:0.013143:0.007466:0.006523:0.005330
cancer, colorectal cancer (CRC), Wilms' :@0.084240:0.558472:0.480460:0.558472:0.480460:0.542716:0.084240:0.542716:0.012450:0.013143:0.011738:0.012450:0.012508:0.003764:0.005330:0.009410:0.012450:0.012604:0.003848:0.012604:0.005707:0.012508:0.012450:0.006523:0.013143:0.003848:0.009410:0.012450:0.013143:0.011738:0.012450:0.012508:0.005792:0.009410:0.007100:0.015644:0.011680:0.015644:0.007100:0.005330:0.009410:0.018584:0.003848:0.003848:0.018049:0.007466:0.003810:0.005330
tumour, NSCLC, anaplastic  astrocytomas :@0.084240:0.574890:0.480483:0.574890:0.480483:0.559134:0.084240:0.559134:0.006523:0.011699:0.018049:0.012604:0.011699:0.003758:0.005330:0.009159:0.014239:0.009583:0.015644:0.008890:0.015644:0.005330:0.009159:0.013143:0.011738:0.013143:0.013123:0.003848:0.013143:0.007466:0.006523:0.003848:0.012450:0.005330:0.003848:0.013143:0.007466:0.006523:0.005713:0.012604:0.012450:0.010314:0.006523:0.012604:0.018049:0.013143:0.007466:0.005330
and gastric cancer.:@0.084240:0.591307:0.268934:0.591307:0.268934:0.575551:0.084240:0.575551:0.013143:0.011738:0.013181:0.006235:0.012950:0.013143:0.007466:0.006523:0.005792:0.003848:0.012450:0.006235:0.012450:0.013143:0.011738:0.012450:0.012508:0.004374:0.005330
1,9-13:@0.268944:0.585769:0.300636:0.585769:0.300636:0.576584:0.268944:0.576584:0.006215:0.003107:0.006215:0.003724:0.006215:0.006215
 The benefit of ad-:@0.300643:0.591388:0.475143:0.591388:0.475143:0.575632:0.300643:0.575632:0.006238:0.008197:0.011738:0.012508:0.006231:0.013123:0.012508:0.011738:0.012508:0.004686:0.004686:0.006523:0.006225:0.012604:0.006042:0.006235:0.013143:0.013181:0.006388
juvant treatment is not limited to chemo-:@0.084243:0.607806:0.475152:0.607806:0.475152:0.592050:0.084243:0.592050:0.003906:0.011699:0.010660:0.013143:0.011738:0.006523:0.007197:0.006523:0.005711:0.012508:0.013143:0.006523:0.018049:0.012508:0.011738:0.006523:0.007197:0.003848:0.007466:0.007197:0.011738:0.012604:0.006523:0.007187:0.003848:0.003848:0.018049:0.003848:0.006523:0.012508:0.013181:0.007197:0.006523:0.012604:0.007197:0.012450:0.011738:0.012508:0.018049:0.012598:0.006388
therapy  agents.  Patients  with  high-risk :@0.084243:0.624223:0.480486:0.624223:0.480486:0.608467:0.084243:0.608467:0.006523:0.011738:0.012508:0.005792:0.013143:0.013123:0.010314:0.005330:0.010529:0.013143:0.012950:0.012508:0.011738:0.006523:0.007466:0.005330:0.005330:0.010531:0.011392:0.013143:0.006523:0.003848:0.012508:0.011738:0.006523:0.007466:0.005330:0.010531:0.015990:0.003848:0.006523:0.011738:0.005330:0.010533:0.011738:0.003848:0.012950:0.011738:0.006388:0.005792:0.003848:0.007466:0.009660:0.005330
malignant melanoma have improvement :@0.084243:0.640641:0.480488:0.640641:0.480488:0.624885:0.084243:0.624885:0.018049:0.013143:0.003848:0.003848:0.012950:0.011738:0.013143:0.011738:0.006523:0.006494:0.018049:0.012508:0.003848:0.013143:0.011738:0.012604:0.018049:0.013143:0.006489:0.011738:0.013143:0.010660:0.012508:0.006494:0.003848:0.018049:0.013123:0.005717:0.012604:0.010660:0.012508:0.018049:0.012508:0.011738:0.006523:0.005330
in DFS and OS from adjuvant immuno-:@0.084243:0.657058:0.475129:0.657058:0.475129:0.641302:0.084243:0.641302:0.003848:0.011738:0.011488:0.014316:0.009333:0.009583:0.011488:0.013143:0.011738:0.013181:0.011488:0.016722:0.009583:0.011488:0.006042:0.005711:0.012604:0.018049:0.011488:0.013143:0.013181:0.003906:0.011699:0.010660:0.013143:0.011738:0.006523:0.011488:0.003848:0.018049:0.018049:0.011699:0.011738:0.012604:0.006388
therapy treatment  with alpha-interferon :@0.084243:0.673475:0.480492:0.673475:0.480492:0.657719:0.084243:0.657719:0.006523:0.011738:0.012508:0.005792:0.013143:0.013123:0.010314:0.011719:0.006523:0.005709:0.012508:0.013143:0.006523:0.018049:0.012508:0.011738:0.006523:0.005330:0.006379:0.015990:0.003848:0.006523:0.011738:0.011719:0.013143:0.003848:0.013123:0.011738:0.013143:0.006388:0.003848:0.011738:0.006523:0.012508:0.006708:0.006042:0.012508:0.005709:0.012604:0.011738:0.005330
(biologic agent), nivolumab (anti-PD1 im-:@0.084243:0.689893:0.475127:0.689893:0.475127:0.674137:0.084243:0.674137:0.007100:0.013123:0.003848:0.012604:0.003848:0.012604:0.012950:0.003848:0.012450:0.006773:0.013143:0.012950:0.012508:0.011738:0.006523:0.007100:0.005330:0.006773:0.011738:0.003848:0.010660:0.012604:0.003848:0.011699:0.018049:0.013143:0.013123:0.006787:0.007100:0.013143:0.011738:0.006523:0.003848:0.006388:0.011392:0.014316:0.010660:0.006773:0.003848:0.018049:0.006388
munotherapy)  or  ipilimumab  (anti-CTLA4 :@0.084243:0.706310:0.480485:0.706310:0.480485:0.690554:0.084243:0.690554:0.018049:0.011699:0.011738:0.012604:0.006523:0.011738:0.012508:0.005792:0.013143:0.013123:0.010314:0.007100:0.005330:0.004403:0.012604:0.005792:0.005330:0.004407:0.003848:0.013123:0.003848:0.003848:0.003848:0.018049:0.011699:0.018049:0.013143:0.013143:0.005330:0.004412:0.007100:0.013143:0.011738:0.006523:0.003848:0.006388:0.015644:0.008197:0.008890:0.014239:0.010660:0.005330
immunotherapy).:@0.084243:0.722728:0.245802:0.722728:0.245802:0.706972:0.084243:0.706972:0.003848:0.018049:0.018049:0.011699:0.011738:0.012604:0.006523:0.011738:0.012508:0.005792:0.013143:0.013123:0.010314:0.007100:0.005330
14-15:@0.245792:0.717143:0.274376:0.717143:0.274376:0.707957:0.245792:0.707957:0.006215:0.006215:0.003724:0.006215:0.006215
  The  antihormonal :@0.274386:0.722762:0.480481:0.722762:0.480481:0.707006:0.274386:0.707006:0.005330:0.016191:0.008197:0.011738:0.012508:0.005330:0.016181:0.013143:0.011738:0.006523:0.003848:0.011738:0.012604:0.006315:0.018049:0.012604:0.011738:0.013143:0.003848:0.005330
agents  tamoxifen  (anti-oestrogen),  anas-:@0.084251:0.739179:0.475161:0.739179:0.475161:0.723423:0.084251:0.723423:0.013143:0.012950:0.012508:0.011738:0.006523:0.007466:0.005330:0.003081:0.006523:0.013143:0.018049:0.012604:0.009236:0.003848:0.006042:0.012508:0.011738:0.005330:0.003081:0.007100:0.013143:0.011738:0.006523:0.003848:0.006388:0.012604:0.012508:0.007466:0.006523:0.005711:0.012604:0.012950:0.012508:0.011738:0.007100:0.005330:0.005330:0.003079:0.013143:0.011738:0.013143:0.007466:0.006388
trozole and letrozole (both aromatase in-:@0.084251:0.755597:0.475169:0.755597:0.475169:0.739841:0.084251:0.739841:0.006523:0.005711:0.012604:0.008178:0.012604:0.003848:0.012508:0.007429:0.013143:0.011738:0.013181:0.007447:0.003848:0.012508:0.006523:0.005711:0.012604:0.008178:0.012604:0.003848:0.012508:0.007431:0.007100:0.013123:0.012604:0.006523:0.011738:0.007437:0.013143:0.005715:0.012604:0.018049:0.013143:0.006523:0.013143:0.007466:0.012508:0.007447:0.003848:0.011738:0.006388
hibitors) are active agents in the adjuvant :@0.084251:0.772014:0.480510:0.772014:0.480510:0.756258:0.084251:0.756258:0.011738:0.003848:0.013123:0.003848:0.006523:0.012604:0.005792:0.007466:0.007100:0.005619:0.013143:0.005715:0.012508:0.005619:0.013143:0.012450:0.006523:0.003848:0.010660:0.012508:0.005619:0.013143:0.012950:0.012508:0.011738:0.006523:0.007466:0.005619:0.003848:0.011738:0.005619:0.006523:0.011738:0.012508:0.005619:0.013143:0.013181:0.003906:0.011699:0.010660:0.013143:0.011738:0.006523:0.005330
therapy of postmenopausal women with :@0.084251:0.788431:0.480491:0.788431:0.480491:0.772675:0.084251:0.772675:0.006523:0.011738:0.012508:0.005792:0.013143:0.013123:0.010314:0.008274:0.012604:0.006042:0.008274:0.013123:0.012604:0.007466:0.006523:0.018049:0.012508:0.011738:0.012604:0.013123:0.013143:0.011699:0.007466:0.013143:0.003848:0.008274:0.015990:0.012604:0.018049:0.012508:0.011738:0.008274:0.015990:0.003848:0.006523:0.011738:0.005330
hormone receptor-positive breast tumours :@0.084251:0.804849:0.480516:0.804849:0.480516:0.789093:0.084251:0.789093:0.011738:0.012604:0.006317:0.018049:0.012604:0.011738:0.012508:0.004949:0.005711:0.012508:0.012450:0.012508:0.013123:0.006523:0.012604:0.005792:0.006388:0.013123:0.012604:0.007466:0.003848:0.006523:0.003848:0.010660:0.012508:0.004965:0.013123:0.005715:0.012508:0.013143:0.007466:0.006523:0.004965:0.006523:0.011699:0.018049:0.012604:0.011699:0.005792:0.007466:0.005330
cancer. Anti-hormone treatment is usually :@0.084251:0.821266:0.480487:0.821266:0.480487:0.805510:0.084251:0.805510:0.012450:0.013143:0.011738:0.012450:0.012508:0.004376:0.005330:0.006023:0.014239:0.011738:0.006523:0.003848:0.006388:0.011738:0.012590:0.006323:0.018049:0.012604:0.011738:0.012508:0.006009:0.006523:0.005711:0.012508:0.013143:0.006523:0.018049:0.012508:0.011738:0.006523:0.006011:0.003848:0.007466:0.006023:0.011699:0.007466:0.011699:0.013143:0.003848:0.003848:0.010314:0.005330
administered  for  five  to  10  years.:@0.084251:0.837684:0.406833:0.837684:0.406833:0.821928:0.084251:0.821928:0.013143:0.013181:0.018049:0.003848:0.011738:0.003848:0.007466:0.006523:0.012508:0.005719:0.012508:0.013181:0.005330:0.004451:0.006042:0.012604:0.005792:0.005330:0.004441:0.004686:0.004686:0.010660:0.012508:0.005330:0.004449:0.006523:0.012604:0.005330:0.004443:0.010660:0.010660:0.005330:0.004458:0.010314:0.012508:0.013143:0.005792:0.007466:0.005330
16,17:@0.406823:0.832095:0.434790:0.832095:0.434790:0.822909:0.406823:0.822909:0.006215:0.006215:0.003107:0.006215:0.006215
 Re-:@0.434797:0.837714:0.475148:0.837714:0.475148:0.821958:0.434797:0.821958:0.009775:0.011680:0.012508:0.006388
cent clinical trials have shown that adju-:@0.084239:0.854131:0.475135:0.854131:0.475135:0.838375:0.084239:0.838375:0.012450:0.012508:0.011738:0.006523:0.008005:0.012450:0.003848:0.003848:0.011738:0.003848:0.012450:0.013143:0.003848:0.008016:0.006523:0.005792:0.003848:0.013143:0.003848:0.007466:0.008018:0.011738:0.013143:0.010660:0.012508:0.008005:0.007466:0.011738:0.012604:0.015990:0.011738:0.008005:0.006523:0.011738:0.013143:0.006523:0.008005:0.013143:0.013181:0.003906:0.011699:0.006388
vant imatinib therapy (a targeted therapy :@0.084239:0.870548:0.480488:0.870548:0.480488:0.854792:0.084239:0.854792:0.010660:0.013143:0.011738:0.006523:0.005013:0.003848:0.018049:0.013143:0.006523:0.003848:0.011738:0.003848:0.013123:0.005022:0.006523:0.011738:0.012508:0.005792:0.013143:0.013123:0.010314:0.005007:0.007100:0.013143:0.005022:0.006523:0.013143:0.005807:0.012950:0.012508:0.006523:0.012508:0.013181:0.005003:0.006523:0.011738:0.012508:0.005792:0.013143:0.013123:0.010314:0.005330
against C-Kit/CD117) given  to  patients :@0.084239:0.886966:0.480473:0.886966:0.480473:0.871210:0.084239:0.871210:0.013143:0.012950:0.013143:0.003848:0.011738:0.007466:0.006523:0.013797:0.015644:0.006388:0.011372:0.003848:0.006523:0.008409:0.015644:0.014316:0.010660:0.010660:0.010660:0.007100:0.013797:0.012950:0.003848:0.010660:0.012508:0.011738:0.005330:0.008457:0.006523:0.012604:0.005330:0.008451:0.013123:0.013143:0.006523:0.003848:0.012508:0.011738:0.006523:0.007466:0.005330
with surgically resected  gastro-intestinal :@0.084239:0.903383:0.480476:0.903383:0.480476:0.887627:0.084239:0.887627:0.015990:0.003848:0.006523:0.011738:0.012873:0.007466:0.011699:0.005809:0.012950:0.003848:0.012450:0.013143:0.003848:0.003848:0.010314:0.012873:0.005713:0.012508:0.007466:0.012508:0.012450:0.006523:0.012508:0.013181:0.005330:0.007531:0.012950:0.013143:0.007466:0.006523:0.005709:0.012604:0.006388:0.003848:0.011738:0.006523:0.012508:0.007466:0.006523:0.003848:0.011738:0.013143:0.003848:0.005330
stromal tumours  (GIST) is more effective :@0.084239:0.919801:0.480475:0.919801:0.480475:0.904045:0.084239:0.904045:0.007466:0.006523:0.005713:0.012604:0.018049:0.013143:0.003848:0.010660:0.006523:0.011699:0.018049:0.012604:0.011699:0.005792:0.007466:0.005330:0.005319:0.007100:0.016779:0.004349:0.009583:0.008197:0.007100:0.010660:0.003848:0.007466:0.010660:0.018049:0.012604:0.005709:0.012508:0.010660:0.012508:0.006096:0.006042:0.012508:0.012450:0.006523:0.003848:0.010660:0.012508:0.005330
when given for three years as opposed to :@0.084239:0.936218:0.480498:0.936218:0.480498:0.920462:0.084239:0.920462:0.015990:0.011738:0.012508:0.011738:0.005753:0.012950:0.003848:0.010660:0.012508:0.011738:0.005753:0.006042:0.012604:0.005792:0.005742:0.006523:0.011738:0.005707:0.012508:0.012508:0.005753:0.010314:0.012508:0.013143:0.005792:0.007466:0.005753:0.013143:0.007466:0.005753:0.012604:0.013123:0.013123:0.012604:0.007466:0.012508:0.013181:0.005753:0.006523:0.012604:0.005330
one  year.   Cancers  with  proven  benefit :@0.523639:0.672706:0.919887:0.672734:0.919887:0.656978:0.523639:0.656950:0.012604:0.011738:0.012508:0.005330:0.004066:0.010314:0.012508:0.013143:0.004380:0.005330:0.012430:0.005330:0.004074:0.015644:0.013143:0.011738:0.012450:0.012508:0.005792:0.007466:0.005330:0.004070:0.015990:0.003848:0.006523:0.011738:0.005330:0.004074:0.013123:0.005715:0.012604:0.010660:0.012508:0.011738:0.005330:0.004074:0.013123:0.012508:0.011738:0.012508:0.004686:0.004686:0.006523:-0.415616
18:@0.615553:0.667115:0.627983:0.667115:0.627983:0.657929:0.615553:0.657929:0.006215:0.006215
to adjuvant treatment are summarised in :@0.523636:0.689019:0.919872:0.689019:0.919872:0.673263:0.523636:0.673263:0.006523:0.012604:0.007277:0.013143:0.013181:0.003906:0.011699:0.010660:0.013143:0.011738:0.006523:0.007279:0.006523:0.005711:0.012508:0.013143:0.006523:0.018049:0.012508:0.011738:0.006523:0.007276:0.013143:0.005713:0.012508:0.007283:0.007466:0.011699:0.018049:0.018049:0.013143:0.005792:0.003848:0.007466:0.012508:0.013181:0.007293:0.003848:0.011738:0.005330
Table 3.:@0.523636:0.705304:0.594775:0.705304:0.594775:0.689548:0.523636:0.689548:0.007197:0.013143:0.013123:0.003848:0.012508:0.005330:0.010660:0.005330
COMBINATION CHEMOTHERAPY :@0.523636:0.738523:0.889113:0.738523:0.889113:0.718926:0.523636:0.718926:0.018344:0.019756:0.021167:0.013641:0.006585:0.017404:0.017404:0.009878:0.006585:0.019756:0.017404:0.006585:0.018344:0.015993:0.012230:0.021167:0.019756:0.009878:0.015993:0.012230:0.013641:0.017404:0.013170:0.014581:0.006585
Historically,  combination chemotherapy :@0.523636:0.757102:0.919889:0.757102:0.919889:0.741346:0.523636:0.741346:0.013143:0.003848:0.007466:0.006523:0.012604:0.005792:0.003848:0.012450:0.013143:0.003848:0.003848:0.010314:0.005330:0.005330:0.008980:0.012450:0.012604:0.018049:0.013123:0.003848:0.011738:0.013143:0.006523:0.003848:0.012604:0.011738:0.014297:0.012450:0.011738:0.012508:0.018049:0.012604:0.006523:0.011738:0.012508:0.005792:0.013143:0.013123:0.010314:0.005330
started when several active drugs from dif-:@0.523636:0.773387:0.914555:0.773387:0.914555:0.757631:0.523636:0.757631:0.007466:0.006523:0.013143:0.005792:0.006523:0.012508:0.013181:0.004293:0.015990:0.011738:0.012508:0.011738:0.004293:0.007466:0.012508:0.010660:0.012508:0.005792:0.013143:0.003848:0.004310:0.013143:0.012450:0.006523:0.003848:0.010660:0.012508:0.004310:0.013181:0.005792:0.011699:0.012950:0.007466:0.004297:0.006042:0.005711:0.012604:0.018049:0.004295:0.013181:0.003848:0.006042:0.006388
ferent classes were used in the treatment :@0.523636:0.789672:0.919900:0.789672:0.919900:0.773916:0.523636:0.773916:0.006042:0.012508:0.005709:0.012508:0.011738:0.006523:0.006725:0.012450:0.003848:0.013143:0.007466:0.007466:0.012508:0.007466:0.006746:0.015990:0.012508:0.005709:0.012508:0.006735:0.011699:0.007466:0.012508:0.013181:0.006735:0.003848:0.011738:0.006735:0.006523:0.011738:0.012508:0.006735:0.006523:0.005711:0.012508:0.013143:0.006523:0.018049:0.012508:0.011738:0.006523:0.005330
of the acute leukaemias and lymphomas. :@0.523636:0.805957:0.919875:0.805957:0.919875:0.790201:0.523636:0.790201:0.012604:0.006042:0.005511:0.006523:0.011738:0.012508:0.005507:0.013143:0.012450:0.011699:0.006523:0.012508:0.005511:0.003848:0.012508:0.011699:0.009660:0.013143:0.012508:0.018049:0.003848:0.013143:0.007466:0.005523:0.013143:0.011738:0.013181:0.005523:0.003848:0.010314:0.018049:0.013123:0.011738:0.012604:0.018049:0.013143:0.007466:0.005330:0.005330
Following the initial success with hemato-:@0.523636:0.822242:0.914545:0.822242:0.914545:0.806486:0.523636:0.806486:0.009333:0.012604:0.003848:0.003848:0.012604:0.015990:0.003848:0.011738:0.012950:0.007201:0.006523:0.011738:0.012508:0.007197:0.003848:0.011738:0.003848:0.006523:0.003848:0.013143:0.003848:0.007216:0.007466:0.011699:0.012450:0.012450:0.012508:0.007466:0.007466:0.007216:0.015990:0.003848:0.006523:0.011738:0.007204:0.011738:0.012508:0.018049:0.013143:0.006523:0.012592:0.006388
logic malignancies, combination chemo-:@0.523636:0.838527:0.914545:0.838527:0.914545:0.822771:0.523636:0.822771:0.003848:0.012604:0.012950:0.003848:0.012450:0.007254:0.018049:0.013143:0.003848:0.003848:0.012950:0.011738:0.013143:0.011738:0.012450:0.003848:0.012508:0.007466:0.005330:0.007254:0.012450:0.012604:0.018049:0.013123:0.003848:0.011738:0.013143:0.006523:0.003848:0.012604:0.011738:0.007245:0.012450:0.011738:0.012508:0.018049:0.012594:0.006388
therapy was extended to the treatment of :@0.523636:0.854812:0.919900:0.854812:0.919900:0.839056:0.523636:0.839056:0.006523:0.011738:0.012508:0.005792:0.013143:0.013123:0.010314:0.004676:0.015990:0.013143:0.007466:0.004676:0.012508:0.009236:0.006523:0.012508:0.011738:0.013181:0.012508:0.013181:0.004676:0.006523:0.012604:0.004676:0.006523:0.011738:0.012508:0.004676:0.006523:0.005711:0.012508:0.013143:0.006523:0.018049:0.012508:0.011738:0.006523:0.004666:0.012604:0.006042:0.005330
solid tumours. :@0.523636:0.871098:0.654407:0.871098:0.654407:0.855342:0.523636:0.855342:0.007466:0.012604:0.003848:0.003848:0.013181:0.005330:0.006523:0.011699:0.018049:0.012604:0.011699:0.005792:0.007466:0.005330:0.005330
When several agents of a class are avail-:@0.541820:0.887383:0.914545:0.887383:0.914545:0.871627:0.541820:0.871627:0.018473:0.011738:0.012508:0.011738:0.004199:0.007466:0.012508:0.010660:0.012508:0.005792:0.013143:0.003848:0.004214:0.013143:0.012950:0.012508:0.011738:0.006523:0.007466:0.004201:0.012604:0.006042:0.004203:0.013143:0.004214:0.012450:0.003848:0.013143:0.007466:0.007466:0.004214:0.013143:0.005713:0.012508:0.004204:0.013143:0.010660:0.013143:0.003848:0.003862:0.006388
able and are equally  effective, a drug :@0.523636:0.903668:0.919866:0.903668:0.919866:0.887912:0.523636:0.887912:0.013143:0.013123:0.003848:0.012508:0.010853:0.013143:0.011738:0.013181:0.010853:0.013143:0.005715:0.012508:0.010853:0.012508:0.013123:0.011699:0.013143:0.003848:0.003848:0.010314:0.005330:0.005536:0.012508:0.006096:0.006042:0.012508:0.012450:0.006523:0.003848:0.010660:0.012508:0.005330:0.010853:0.013143:0.010853:0.013181:0.005792:0.011699:0.012950:0.005330
should be chosen  by a principle of  non-:@0.523636:0.919953:0.914582:0.919953:0.914582:0.904197:0.523636:0.904197:0.007466:0.011738:0.012604:0.011699:0.003848:0.013181:0.008332:0.013123:0.012508:0.008332:0.012450:0.011738:0.012604:0.007466:0.012508:0.011738:0.005330:0.002992:0.013123:0.010314:0.008332:0.013143:0.008332:0.013123:0.005792:0.003848:0.011738:0.012450:0.003848:0.013123:0.003848:0.012508:0.008332:0.012604:0.006042:0.005330:0.002990:0.011738:0.012604:0.011738:0.006388
overlapping toxicities. This methodology :@0.523636:0.936238:0.919875:0.936238:0.919875:0.920482:0.523636:0.920482:0.012604:0.010660:0.012508:0.005792:0.003848:0.013143:0.013123:0.013123:0.003848:0.011738:0.012950:0.011738:0.006523:0.012604:0.009236:0.003848:0.012450:0.003848:0.006523:0.003848:0.012508:0.007466:0.005330:0.011738:0.008197:0.011738:0.003848:0.007466:0.011738:0.018049:0.012508:0.006523:0.011738:0.012604:0.013181:0.012604:0.003848:0.012604:0.012950:0.010314:0.005330
Table 3. Cancers treated with adjuvant :@0.523636:0.096159:0.881733:0.096159:0.881733:0.080126:0.523636:0.080126:0.007889:0.012508:0.012508:0.004426:0.012123:0.005195:0.010583:0.005195:0.005195:0.014817:0.012508:0.011353:0.012123:0.012123:0.005965:0.008274:0.005195:0.005580:0.005965:0.012123:0.012508:0.005580:0.012123:0.012508:0.005195:0.015202:0.004426:0.005580:0.011353:0.005195:0.012508:0.012508:0.004811:0.011353:0.010583:0.012508:0.011353:0.005769:0.005388
chemotherapy and other systemic :@0.523636:0.112325:0.844601:0.112325:0.844601:0.096292:0.523636:0.096292:0.012123:0.011353:0.012123:0.017895:0.012123:0.005580:0.011353:0.012123:0.005965:0.012508:0.012508:0.010968:0.005195:0.012508:0.011353:0.012508:0.005195:0.012123:0.005580:0.011353:0.012123:0.005965:0.005195:0.008274:0.010968:0.008274:0.005580:0.012123:0.017895:0.004426:0.012317:0.005388
treatments:@0.523636:0.128492:0.620810:0.128492:0.620810:0.112458:0.523636:0.112458:0.005580:0.005965:0.012123:0.012508:0.005580:0.017895:0.012123:0.011353:0.005580:0.008467
Chemotherapy:@0.533261:0.159256:0.672769:0.159256:0.672769:0.143222:0.533261:0.143222:0.014817:0.011353:0.012123:0.017895:0.012123:0.005580:0.011353:0.012123:0.005965:0.012508:0.012508:0.011161
Breast cancer :@0.533261:0.181679:0.668403:0.181679:0.668403:0.165923:0.533261:0.165923:0.011045:0.005717:0.012508:0.013143:0.007466:0.006523:0.005330:0.012450:0.013143:0.011738:0.012450:0.012508:0.005792:0.005330
Colorectal cancer :@0.533261:0.204103:0.710880:0.204103:0.710880:0.188347:0.533261:0.188347:0.015644:0.012604:0.003848:0.012604:0.005707:0.012508:0.012450:0.006523:0.013143:0.003848:0.005330:0.012450:0.013143:0.011738:0.012450:0.012508:0.005792:0.005330
Gastric cancer:@0.533261:0.226526:0.672673:0.226526:0.672673:0.210770:0.533261:0.210770:0.016779:0.013143:0.007466:0.006523:0.005792:0.003848:0.012450:0.005330:0.012450:0.013143:0.011738:0.012450:0.012508:0.005792
Non-small-cell lung cancer (NSCLC) :@0.533261:0.248950:0.871466:0.248950:0.871466:0.233194:0.533261:0.233194:0.014239:0.012604:0.011738:0.006388:0.007466:0.018049:0.013143:0.003848:0.003848:0.006388:0.012450:0.012508:0.003848:0.003848:0.005330:0.003848:0.011699:0.011738:0.012950:0.005330:0.012450:0.013143:0.011738:0.012450:0.012508:0.005792:0.005330:0.007100:0.014239:0.009583:0.015644:0.008890:0.015644:0.007100:0.005330
Wilms’ tumour:@0.533261:0.271373:0.663509:0.271373:0.663509:0.255617:0.533261:0.255617:0.018584:0.003848:0.003848:0.018049:0.007466:0.006754:0.005330:0.006523:0.011699:0.018049:0.012604:0.011699:0.005792
Osteogenic sarcoma:@0.533261:0.293797:0.730415:0.293797:0.730415:0.278041:0.533261:0.278041:0.016722:0.007466:0.006523:0.012508:0.012604:0.012950:0.012508:0.011738:0.003848:0.012450:0.005330:0.007466:0.013143:0.005653:0.012450:0.012604:0.018049:0.013143
Anaplastic astrocytomas :@0.533261:0.316220:0.769446:0.316220:0.769446:0.300464:0.533261:0.300464:0.014239:0.011738:0.013143:0.013123:0.003848:0.013143:0.007466:0.006523:0.003848:0.012450:0.005330:0.013143:0.007466:0.006523:0.005719:0.012604:0.012450:0.010314:0.006523:0.012604:0.018049:0.013143:0.007466:0.005330
Biological agents:@0.533261:0.338643:0.691049:0.338643:0.691049:0.322610:0.533261:0.322610:0.010968:0.004426:0.012123:0.004426:0.012123:0.012508:0.004426:0.012123:0.012508:0.004426:0.005195:0.012508:0.012508:0.012123:0.011353:0.005580:0.008467
Malignant melanoma: alpha-interferon, :@0.533261:0.361067:0.908914:0.361067:0.908914:0.345311:0.533261:0.345311:0.017684:0.013143:0.003848:0.003848:0.012950:0.011738:0.013143:0.011738:0.006523:0.005330:0.018049:0.012508:0.003848:0.013143:0.011738:0.012604:0.018049:0.013143:0.005330:0.005330:0.013143:0.003848:0.013123:0.011738:0.013143:0.006388:0.003848:0.011738:0.006523:0.012508:0.006704:0.006042:0.012508:0.005709:0.012604:0.011738:0.005330:0.005330
Malignant melanoma: nivolumab (anti-:@0.533261:0.383490:0.899733:0.383490:0.899733:0.367734:0.533261:0.367734:0.017684:0.013143:0.003848:0.003848:0.012950:0.011738:0.013143:0.011738:0.006523:0.005330:0.018049:0.012508:0.003848:0.013143:0.011738:0.012604:0.018049:0.013143:0.005330:0.005330:0.011738:0.003848:0.010660:0.012604:0.003848:0.011699:0.018049:0.013143:0.013123:0.005330:0.007100:0.013143:0.011738:0.006523:0.003848:0.006388
PD1), ipilimumab (anti-CTLA-4) :@0.533261:0.399656:0.820493:0.399656:0.820493:0.383900:0.533261:0.383900:0.011392:0.014316:0.010660:0.007100:0.005330:0.005330:0.003848:0.013123:0.003848:0.003848:0.003848:0.018049:0.011699:0.018049:0.013143:0.013123:0.005330:0.007100:0.013143:0.011738:0.006523:0.003848:0.006388:0.015644:0.008197:0.008890:0.014239:0.006388:0.010660:0.007100:0.005330
Breast cancer: transtuzumab (anti-:@0.533261:0.422080:0.854881:0.422080:0.854881:0.406324:0.533261:0.406324:0.011045:0.005717:0.012508:0.013143:0.007466:0.006523:0.005330:0.012450:0.013143:0.011738:0.012450:0.012508:0.005792:0.005330:0.005330:0.006523:0.005792:0.013143:0.011738:0.007466:0.006523:0.011699:0.008178:0.011699:0.018049:0.013143:0.013123:0.005330:0.007100:0.013143:0.011738:0.006523:0.003848:0.006388
HER2) :@0.533261:0.438246:0.591489:0.438246:0.591489:0.422490:0.533261:0.422490:0.013143:0.010314:0.011680:0.010660:0.007100:0.005330
Antihormones:@0.533261:0.460669:0.660069:0.460669:0.660069:0.444635:0.533261:0.444635:0.014047:0.011353:0.005580:0.004426:0.011353:0.012123:0.005965:0.017895:0.012123:0.011353:0.012123:0.008467
Breast cancer (hormone receptor :@0.533261:0.483093:0.852918:0.483093:0.852918:0.467337:0.533261:0.467337:0.011045:0.005717:0.012508:0.013143:0.007466:0.006523:0.005330:0.012450:0.013143:0.011738:0.012450:0.012508:0.005792:0.005330:0.007100:0.011738:0.012604:0.006308:0.018049:0.012604:0.011738:0.012508:0.005330:0.005700:0.012508:0.012450:0.012508:0.013123:0.006523:0.012604:0.005792:0.005330
positive):@0.533261:0.499259:0.610943:0.499259:0.610943:0.483503:0.533261:0.483503:0.013123:0.012604:0.007466:0.003848:0.006523:0.003848:0.010660:0.012508:0.007100
Tamoxifen (anti-oestrogen) :@0.533261:0.521682:0.788733:0.521682:0.788733:0.505926:0.533261:0.505926:0.007197:0.013143:0.018049:0.012604:0.009236:0.003848:0.006042:0.012508:0.011738:0.005330:0.007100:0.013143:0.011738:0.006523:0.003848:0.006388:0.012604:0.012508:0.007466:0.006523:0.005705:0.012604:0.012950:0.012508:0.011738:0.007100:0.005330
Anastrozole and letrozole (aromatase :@0.533261:0.544106:0.888901:0.544106:0.888901:0.528350:0.533261:0.528350:0.014239:0.011738:0.013143:0.007466:0.006523:0.005707:0.012604:0.008178:0.012604:0.003848:0.012508:0.005330:0.013143:0.011738:0.013181:0.005330:0.003848:0.012508:0.006523:0.005698:0.012604:0.008178:0.012604:0.003848:0.012508:0.005330:0.007100:0.013143:0.005703:0.012604:0.018049:0.013143:0.006523:0.013143:0.007466:0.012508:0.005330
inhibitors) :@0.533261:0.560272:0.626221:0.560272:0.626221:0.544516:0.533261:0.544516:0.003848:0.011738:0.011738:0.003848:0.013123:0.003848:0.006523:0.012604:0.005792:0.007466:0.007100:0.005330
Targeted therapy:@0.533261:0.582695:0.690857:0.582695:0.690857:0.566661:0.533261:0.566661:0.007889:0.012508:0.005965:0.012508:0.012123:0.005580:0.012123:0.012508:0.005195:0.005580:0.011353:0.012123:0.005965:0.012508:0.012508:0.011161
GIST: Gastro-intestinal stromal tumour :@0.533261:0.605119:0.882388:0.605119:0.882388:0.589363:0.533261:0.589363:0.016779:0.004349:0.009583:0.008253:0.005330:0.005330:0.016779:0.013143:0.007466:0.006523:0.005711:0.012604:0.006388:0.003848:0.011738:0.006523:0.012508:0.007466:0.006523:0.003848:0.011738:0.013143:0.003848:0.005330:0.007466:0.006523:0.005713:0.012604:0.018049:0.013143:0.003848:0.005330:0.006523:0.011699:0.018049:0.012604:0.011699:0.005792:0.005330
Imatinib therapy (a targeted therapy :@0.533261:0.627542:0.884199:0.627542:0.884199:0.611786:0.533261:0.611786:0.004349:0.018049:0.013143:0.006523:0.003848:0.011738:0.003848:0.013123:0.005330:0.006523:0.011738:0.012508:0.005792:0.013143:0.013123:0.010314:0.005330:0.007100:0.013143:0.005330:0.006523:0.013143:0.005805:0.012950:0.012508:0.006523:0.012508:0.013181:0.005330:0.006523:0.011738:0.012508:0.005792:0.013143:0.013123:0.010314:0.005330
against C-Kit/CD117):@0.533261:0.643708:0.728629:0.643708:0.728629:0.627952:0.533261:0.627952:0.013143:0.012950:0.013143:0.003848:0.011738:0.007466:0.006523:0.005330:0.015644:0.006388:0.011372:0.003848:0.006523:0.008409:0.015644:0.014316:0.010660:0.010660:0.010660:0.007100